Atrial fibrillation is characterized by irregular and rapid atrial electrical activity leading to ineffective atrial contraction, which increases the risk of thrombus formation and ischemic stroke, particularly in patients with elevated CHA2DS2-VASc scores who benefit from anticoagulation therapy.